NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.
复制标题
DOI：
10.6004/jnccn.2007.2002
复制
发表时间：
2007-07
期刊：
影响因子：
--
通讯作者：
G. Demetri;R. Benjamin;C. Blanke;J. Blay;P. Casali;Haesun Choi;C. Corless;M. Debiec-Rychter;R. DeMatteo;D. Ettinger;G. Fisher;C. Fletcher;A. Gronchi;P. Hohenberger;M. Hughes;H. Joensuu;I. Judson;A. Le Cesne;R. Maki;M. Morse;A. Pappo;P. Pisters;C. Raut;P. Reichardt;D. Tyler;A. D. Van den Abbeele;M. von Mehren;J. Wayne;J. Zalcberg
中科院分区：
文献类型：
--
作者：
G. Demetri;R. Benjamin;C. Blanke;J. Blay;P. Casali;Haesun Choi;C. Corless;M. Debiec-Rychter;R. DeMatteo;D. Ettinger;G. Fisher;C. Fletcher;A. Gronchi;P. Hohenberger;M. Hughes;H. Joensuu;I. Judson;A. Le Cesne;R. Maki;M. Morse;A. Pappo;P. Pisters;C. Raut;P. Reichardt;D. Tyler;A. D. Van den Abbeele;M. von Mehren;J. Wayne;J. Zalcberg
NCCN软组织肉瘤指南包括一个关于胃肠道间质瘤（GIST）治疗建议的小节。在引入有效的GIST分子靶向治疗（如伊马替尼和舒尼替尼）后，实践标准迅速改变。由于这些变化，NCCN组织了一个由医学肿瘤学、分子诊断学、病理学、放射肿瘤学和手术领域的专家组成的多学科小组，讨论在疾病的各个阶段护理GIST患者的最佳方法。GIST工作组由NCCN教师和来自美国，欧洲和澳大利亚的其他主要专家组成。该工作组于2003年10月首次开会，并于2006年12月再次开会，目的是扩大现有的NCCN胃肠道肉瘤指南，并确定未来的研究领域，以优化我们对GIST的理解和治疗。
The NCCN Soft Tissue Sarcoma Guidelines include a subsection about treatment recommendations for gastrointestinal stromal tumors (GISTs). The standard of practice rapidly changed after the introduction of effective molecularly targeted therapy (such as imatinib and sunitinib) for GIST. Because of these changes, NCCN organized a multidisciplinary panel composed of experts in the fields of medical oncology, molecular diagnostics, pathology, radiation oncology, and surgery to discuss the optimal approach for the care of patients with GIST at all stages of the disease. The GIST Task Force is composed of NCCN faculty and other key experts from the United States, Europe, and Australia. The Task Force met for the first time in October 2003 and again in December 2006 with the purpose of expanding on the existing NCCN guidelines for gastrointestinal sarcomas and identifying areas of future research to optimize our understanding and treatment of GIST.